SCHEMBL22647601

SCHEMBL22647601

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccccc1-c1ccc(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.38
IDO2 Q6ZQW0 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ADORA3 P0DMS8 2/20 0.36
PSMB5 P28074 1/20 0.35
NLRP3 Q96P20 1/20 0.35
DHODH Q02127 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
LMNA P02545 3/20 0.35
TP53 P04637 2/20 0.35
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22647513 0.96 TDO2 (0.38) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL22647603 0.96 TDO2 (0.38) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL22647512 0.96 TDO2 (0.38) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL21375537 0.94 TDO2 (0.40) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL20648349 0.94 TDO2 (0.40) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL25782608 0.92 ALDH1A1 (0.40) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL22647377 0.92 ALDH1A1 (0.35) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL24124494 0.91 ADORA3 (0.38) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL22171732 0.91 TDO2 (0.40) TDO2IDO2L3MBTL1CYP1A2CYP3A4
SCHEMBL21374686 0.91 TDO2 (0.41) TDO2IDO2L3MBTL1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200358002-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200358002-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, AOX1, IKZF3 TDO2 26/4885IDO2 424/4885L3MBTL1 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.